TREATMENT OF DEMYELINATING DISORDERS WITH SOLUBLE LYMPHOTOXIN-BETA-RECEPTOR
- 专利权人:
- 发明人:
- 申请号：
- HK11110969.3
- 公开号：
- HK1156534A
- 申请日:
- 2009.12.21
- 申请国别(地区):
- HK
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention relates to use lymphotoxin-beta-receptor (LT β R) as lymphotoxin pathway inhibitors to treat demyelinating disease such as multiple sclerosis.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- A new method for the treatment of multiple sclerosis.
- TREATMENT OF DEMYELINATING DISORDER WITH SOLUBLE LYMPHOTOXIN &bgr； RECEPTOR
- Pyrethrin [3.4-b] Pyrethrin-5-Ona compound, PI3K inhibitor； drug synthesis containing these substances； used in the treatment of diseases such as Alzheimer's disease, epilepsy, multiple sclerosis, Parkinson's disease.
- Treatment of autoimmune disorders
- S1P RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS
